Ekso Bionics Holdings Inc (OQ:EKSO)

Business Focus: Medical Equipment, Supplies & Distribution

Oct 30, 2019 04:05 pm ET
Ekso Bionics Reports Third Quarter 2019 Results
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended September 30, 2019. Recent Highlights and...
Oct 23, 2019 08:00 am ET
Ekso Bionics® to Report Third Quarter 2019 Financial Results on October 30, 2019
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2019 after the close of trading on...
Sep 23, 2019 04:05 pm ET
Ekso Bionics to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that Jack Peurach, President and Chief Executive Officer of Ekso Bionics, will present at the Cantor Fitzgerald Global...
Aug 15, 2019 08:00 am ET
Ekso Bionics® Unveils the Next Generation Exoskeleton for Neurorehabilitation
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), a leading developer of exoskeletons for medical and industrial use, today unveiled EksoNR, the next generation EksoGT— the most clinically used robotic exoskeleton. Developed for neurorehabilitation,...
Aug 01, 2019 04:05 pm ET
Ekso Bionics Reports Second Quarter 2019 Results
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30, 2019. Recent Highlights and...
Jul 25, 2019 04:05 pm ET
Ekso Bionics® to Report Second Quarter 2019 Financial Results on August 1, 2019
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2019 after the close of trading on...
Jul 24, 2019 08:00 am ET
Ekso Bionics® Expands Its Medical Portfolio with Upper Body Exoskeleton for Rehabilitation
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced the expansion of its medical exoskeleton portfolio with an upper extremity rehabilitation device called EksoUE....
May 24, 2019 04:01 pm ET
Ekso Bionics Announces Closing of $10 Million Public Offering
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company,” “Ekso” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, announced today the closing of its previously announced underwritten public offering...
May 22, 2019 09:14 am ET
Ekso Bionics Announces Pricing of $10 Million Public Offering
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company,” “Ekso” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, announced today the pricing of its previously announced underwritten public offering...
May 21, 2019 04:01 pm ET
Ekso Bionics Announces Proposed Public Offering of Common Stock and Warrants
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company,” “Ekso” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it is commencing an underwritten public offering of shares of...
May 06, 2019 08:01 am ET
Ekso Bionics®’ EksoGT Exoskeleton Adopted in Singapore for Groundbreaking Clinical Study
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that the National University Health System (NUHS) in Singapore has adopted three EksoGT exoskeletons for a...
May 06, 2019 08:00 am ET
Ekso Bionics Announces Appointment of Bill Shaw as Chief Commercial Officer
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Bill Shaw as Chief Commercial Officer, with a start date of May 6, 2019....
May 03, 2019 08:00 am ET
Kindred Hospital Rehabilitation Services Expands Pilot of Ekso Bionics®’ EksoGT Exoskeleton to Enhance Stroke Rehabilitation Offering
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Kindred Hospital Rehabilitation Services ("Kindred"), a division of Kindred Healthcare, has expanded their...
May 01, 2019 04:05 pm ET
Ekso Bionics Reports First Quarter 2019 Results
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2019. Recent Highlights and...
Apr 24, 2019 08:00 am ET
Ekso Bionics® to Report First Quarter 2019 Financial Results on May 1, 2019
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2019 after the close of trading on...
Feb 28, 2019 04:05 pm ET
Ekso Bionics Reports Fourth Quarter and Year End 2018 Results
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2018. Recent Highlights and...
Feb 21, 2019 08:00 am ET
Ekso Bionics® to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2018 after the close...
Jan 30, 2019 08:36 am ET
Ekso Bionics Announces $100 Million Joint Venture to Develop the Exoskeleton Market in Asia
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that its wholly-owned subsidiary, Ekso Bionics, Inc., has entered into an agreement with Zhejiang Youchuang...
Jan 08, 2019 08:00 am ET
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year ended December 31, 2018. Total...
Dec 10, 2018 08:00 am ET
Ekso Bionics® Secures Purchase Orders for the EksoVest™ from Two Global Aerospace Manufacturers
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has secured purchase orders for the EksoVest™ from two global aerospace manufacturers to create and...
Dec 04, 2018 09:00 am ET
Worldwide Adoption of Ekso Bionics® EksoGT™ Exoskeleton Allows Stroke and Spinal Cord Injury Patients to Take 100 Million Steps to Date
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industry use, today announced that the worldwide adoption of the EksoGT™ exoskeleton has allowed stroke and spinal cord injury patients to take...
Nov 07, 2018 04:05 pm ET
Ekso Bionics Reports Third Quarter 2018 Results
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended September 30, 2018. Recent Highlights and Accomplishments...
Nov 06, 2018 08:00 am ET
Ekso Bionics Appoints Thomas Schreck to its Board of Directors
Ekso Bionics Holdings, Inc. (NASDAQ:  EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Thomas Schreck to its Board of Directors, effective immediately. “We are pleased to...
Oct 31, 2018 08:00 am ET
Ekso Bionics® to Report Third Quarter 2018 Financial Results on November 7, 2018
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2018 after the close of trading on...
Oct 17, 2018 07:50 am ET
Report: Exploring Fundamental Drivers Behind Presidio, NACCO Industries, Ekso Bionics, SAExploration, American Software, and A-Mark Precious Metals — New Horizons, Emerging Trends, and Upcoming Develo
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Presidio, Inc. (NASDAQ:PSDO), NACCO Industries, Inc. (NYSE:NC), Ekso...
Sep 26, 2018 08:00 am ET
Ekso Bionics to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2018
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Peurach, President and Chief Executive Officer of Ekso Bionics, will present at the Cantor Fitzgerald...
Aug 22, 2018 08:30 am ET
Analysis: Positioning to Benefit within Evolent Health, Scorpio Tankers, Pretium Resources, B2Gold, NACCO Industries, and Ekso Bionics — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Evolent Health, Inc (NYSE:EVH), Scorpio Tankers Inc. (NYSE:STNG), Pretium...
Aug 15, 2018 09:00 am ET
Ekso Bionics Receives General Services Administration Listing
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that U.S. government’s General Services Administration (GSA) has added the company to its list of contracted...
Aug 13, 2018 07:30 am ET
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that John (Jack) Glenn has been appointed to the position of Chief Financial Officer. Mr. Glenn brings over 25...
Aug 07, 2018 04:05 pm ET
Ekso Bionics Reports Second Quarter 2018 Results
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30, 2018. Recent Highlights and Accomplishments Shipped 25...
Jul 31, 2018 08:00 am ET
Ekso Bionics® to Report Second Quarter 2018 Financial Results on August 7, 2018
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2018 after the close of trading on...
Jul 05, 2018 04:14 pm ET
Robbins Arroyo LLP: Ekso Bionics Holdings, Inc. (EKSO) Misled Shareholders According to Class Action
Shareholder rights law firm Robbins Arroyo LLP reminds investors that purchasers of Ekso Bionics Holdings, Inc. (NasdaqCM: EKSO) filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between March 15, 2017 and De
Jun 11, 2018 08:10 am ET
Recent Analysis Shows Conagra Brands, Ekso Bionics, Triton International, Taubman Centers, Delta Air Lines, and Hilton Worldwide Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Conagra Brands Inc. (NYSE:CAG), Ekso Bionics Holdings, Inc. (NASDAQ:EKSO),...
May 07, 2018 04:05 pm ET
Ekso Bionics Reports First Quarter 2018 Results
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2018. Recent Highlights and Accomplishments Shipped 24...
Apr 30, 2018 08:00 am ET
Ekso Bionics® to Report First Quarter 2018 Financial Results on May 7, 2018
RICHMOND, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter...
Mar 27, 2018 06:30 pm ET
National Stroke Association and Ekso Bionics® Announce Educational Partnership to Advance Stroke Rehabilitation with Exoskeleton Technology
CENTENNIAL, Colo., and RICHMOND, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- National Stroke Association, a nonprofit that provides stroke education and programs to stroke survivors, caregivers, and the healthcare community, and Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry...
Mar 13, 2018 04:05 pm ET
Ekso Bionics Reports Fourth Quarter and Year End 2017 Results
RICHMOND, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2017.
Mar 13, 2018 02:13 pm ET
Robbins Arroyo LLP: Ekso Bionics Holdings, Inc. (EKSO) Misled Shareholders According to a Recently Filed Class Action
Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Ekso Bionics Holdings, Inc. (NasdaqCM: EKSO) have filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between March 15, 2017 and December 27, 2017. Ekso
Mar 12, 2018 08:00 am ET
Ekso Bionics Announces Executive Leadership Changes; Jack Peurach, co-founder of Ekso Bionics, long-time board member and seasoned executive appointed President and Chief Executive Officer; Charles Li
RICHMOND, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has named Jack Peurach as President and Chief Executive Officer...
Mar 06, 2018 08:00 am ET
Ekso Bionics® to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 
RICHMOND, Calif., March 06, 2018 (GLOBE NEWSWIRE) --  Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter...
Feb 27, 2018 04:41 pm ET
FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics
STEVENSON, Md., Feb. 27, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District...
Feb 24, 2018 08:00 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSO
Pomerantz LLP announces that a class action lawsuit has been filed against EKSO Bionics Holdings, Inc. (“Ekso” or the “Company”) (NASDAQ: EKSO) and certain of its officers. The class action, filed in United States District Court, for the Northern District of California, and docketed under 18-cv-00212, is on behalf of a class consisting of investors who purchased or otherwise acquired the securities of Ekso between March 15, 2017 and December 27, 2017, both dates inclusive (the “Class Period”). Plaintiff seeks to recover compensable damages cause
Feb 23, 2018 11:01 am ET
EKSO BIONICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ekso Bionics Holdings, Inc. To Contact The Firm
NEW YORK, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ekso Bionics Holdings, Inc. (“Ekso Bionics” or the “Company”) (NASDAQ:EKSO).
Feb 13, 2018 10:11 am ET
EKSO DEADLINE: Rosen Law Firm Reminds Ekso Bionics Holdings, Inc. Investors of Important Deadline in First Filed Class Action – EKSO
NEW YORK, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) between March 15, 2017 and December 27, 2017, both dates...
Feb 12, 2018 08:00 am ET
Ekso Bionics® to Expand Clinical Trial Sites for Comparative Multicenter WISE Study
RICHMOND, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will be expanding the first company-sponsored randomized, controlled clinical trial,...
Feb 10, 2018 08:15 am ET
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSO
NEW YORK, Feb. 10, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against EKSO Bionics Holdings, Inc. (“Ekso” or the “Company”) (NASDAQ:EKSO) and certain of its officers.   The class action, filed...
Feb 09, 2018 06:36 pm ET
EKSO BIONICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Ekso Bionics Holdings, Inc. to Contact the Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ekso Bionics Holdings, Inc. (“Ekso Bionics” or the “Company”) (NASDAQ: EKSO).
Feb 07, 2018 08:10 am ET
Report: Exploring Fundamental Drivers Behind Dow Chemical, Bank Of New York Mellon, New York Community, Frontier Communications, TAL Education Group, and Ekso Bionics — New Horizons, Emerging Trends,
NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dow Chemical Company (NYSE:DWDP), Bank Of...
Feb 06, 2018 03:08 pm ET
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Ekso Bionics Holdings, Inc. (“Ekso” or the “Company”) (NASDAQ: 
Feb 05, 2018 08:20 pm ET
DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ekso Bionics Holdings,
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of purchasers of Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso” or the “Company”) securities during the period between March 15, 2017 and December 27, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until March 5, 2018 to seek appointment as lead plaintiff.
Feb 01, 2018 02:33 pm ET
EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Ekso Bionics Holdings, Inc. (“Ekso” or the “Company”) (NASDAQ: EKSO) investors concerning the Company and its officers’ possible violations of federal securities laws.
Jan 27, 2018 07:00 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - EKSO
NEW YORK, Jan. 27, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against EKSO Bionics Holdings, Inc. ("Ekso" or the "Company") (NASDAQ: EKSO) and certain of its officers.   The class action, filed in United States District Court, for the Northern District of California, and docketed under 18-cv-00212, is on behalf of a class consisting of investors who purchased or otherwise acquired the securities of Ekso between March 15, 2017 and December 27, 2017, both dates inclusive (the "Class Period"). Plaintiff seeks to recover compensable damages caused by ...
Jan 26, 2018 04:05 pm ET
Ekso Bionics® Announces Leadership Transition
RICHMOND, Calif., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that its industrial division will now report solely to Thomas Looby, President...
Jan 26, 2018 01:49 pm ET
NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. – EKSO
NEW YORK, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)...
Jan 25, 2018 05:30 am ET
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) To Contact Brower Piven Before The Lead Plainti
STEVENSON, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District...
Jan 22, 2018 07:45 am ET
Report: Exploring Fundamental Drivers Behind Flowers Foods, Mednax, Ekso Bionics, 1st Source, Myers Industries, and USA Compression Partners, LP — New Horizons, Emerging Trends, and Upcoming Developme
NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Flowers Foods, Inc. (NYSE:FLO), Mednax, Inc...
Jan 20, 2018 05:30 am ET
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ekso Bionics Holdings, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of purchasers of Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso” or the “Company”) securities during the period between March 15, 2017 and December 27, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until March 5, 2018 to seek appointment as lead plaintiff.
Jan 19, 2018 05:37 pm ET
EKSO BIONICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Ekso Bionics Holdings, Inc. to Contact the Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ekso Bionics Holdings, Inc. (“Ekso Bionics” or the “Company”) (NASDAQ: EKSO).
Jan 17, 2018 05:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Ekso Bionics Holdings, Inc. (EKSO) and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all persons or entities who purchased or otherwise acquired Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) securities between March 15, 2017 and December 27, 2017 (the “Class Period”). Investors have until March 5, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Jan 14, 2018 02:02 pm ET
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.
OKLAHOMA CITY, Jan. 14, 2018 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on January 2, 2018, a class action lawsuit was filed in the United States District Court for the Eastern District of New York against Ekso...
Jan 12, 2018 03:26 pm ET
EKSO LOSS ALERT: Rosen Law Firm Reminds Ekso Bionics Holdings, Inc. Investors of Important Deadline in First Filed Class Action – EKSO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) between March 15, 2017 and December 27, 2017, both dates inclusive (“Class Period”) of the important March 5, 2018 lead plaintiff deadline in the first class action commenced by the Rosen Law Firm. The lawsuit seeks to recover damages for Ekso investors under the federal securities laws.
Jan 11, 2018 10:58 am ET
Jan 10, 2018 10:00 pm ET
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) To C
STEVENSON, Md, Jan. 10, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District...
Jan 10, 2018 02:41 pm ET
UPDATE - Pomerantz Law Firm Announces the Filing of a Class Action against Ekso Bionics Holdings, Inc. and Certain Officers – EKSO
NEW YORK, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against EKSO Bionics Holdings, Inc. (“Ekso” or the “Company”) (NASDAQ:EKSO) and certain of its officers.   The class action, filed...
Jan 09, 2018 08:00 am ET
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2017 Financial Results
RICHMOND, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year...
Jan 08, 2018 04:23 pm ET
Harwood Feffer LLP Announces Investigation of Ekso Bionics Holdings, Inc.
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Ekso Bionics Holdings, Inc. (“Ekso” or the “Company”) (NASDAQ: EKSO) concerning whether the board has breached its fiduciary duties to shareholders.
Jan 03, 2018 08:00 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Ekso Bionics Holdings, Inc. (EKSO)
NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Ekso Bionics Holdings, Inc. (“Ekso Bionics” or the “Company”) (Nasdaq:EKSO) in the United States District Court...
Jan 03, 2018 05:30 pm ET
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Ekso Bionics Holdings, Inc. (EKSO) and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all persons or entities who purchased or otherwise acquired Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) securities between March 15, 2017 and December 27, 2017 (the “Class Period”). Investors have until March 5, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Jan 02, 2018 10:34 am ET
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. – EKSO
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) between March 15, 2017 and December 27, 2017, both dates inclusive (“Class Period”). The lawsuit seeks to recover damages for Ekso investors under the federal securities laws.
Dec 28, 2017 02:40 pm ET
EKSO BIONICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ekso Bionics Holdings, Inc. To Contact The Firm
NEW YORK, Dec. 28, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ekso Bionics Holdings, Inc. ("Ekso Bionics" or the "Company") (NASDAQ: EKSO)....
Dec 28, 2017 01:38 pm ET
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Ekso Bionics Holdings, Inc.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of purchasers of the securities of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) resulting from allegations that Ekso Bionics may have issued materially misleading business information to the investing public.
Dec 28, 2017 11:05 am ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ekso Bionics Holdings, Inc. (EKSO)
NEW YORK, Dec. 28, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ekso Bionics Holdings, Inc. ("Ekso" or the "Company") (NASDAQ: EKSO). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/ekso. ...
Dec 28, 2017 10:40 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ekso Bionics Holdings, Inc. - EKSO
NEW YORK, Dec. 28, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ekso Bionics Holdings, Inc. ("Ekso" or the "Company") (NASDAQ: EKSO).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980....
Dec 27, 2017 05:30 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Ekso Bionics Holdings, Inc.
Levi & Korsinsky announces it has commenced an investigation of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) concerning possible breaches of fiduciary duty. To obtain additional information, go to:
Dec 14, 2017 08:00 am ET
Ekso Bionics® Partners with HASOMED to Launch Functional Electrical Stimulation (FES) for the EksoGT™ Exoskeleton
Combination of Exoskeleton and RehaStim2 FES Technology Provide Breakthrough Rehabilitative Care
Nov 28, 2017 08:00 am ET
International Journal Spinal Cord Publishes Multicenter Pan-Euro Study of EksoGT™
Data Showcases Potential Benefits in Gait Function and Balance in Broad Range of Severity and Level of Spinal Cord Injury, as well as Time since Injury
Nov 27, 2017 07:55 am ET
Report: Developing Opportunities within OGE Energy, Stratasys, Snap, J.C. Penney Company, Inc. Holding, Micron Technology, and Ekso Bionics — Future Expectations, Projections Moving into 2018
NEW YORK, Nov. 27, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of OGE Energy Corporation (NYSE:OGE), Stratasys, Ltd....
Nov 16, 2017 08:15 am ET
Consolidated Research: 2018 Summary Expectations for Dow Chemical, Bank Of New York Mellon, New York Community, Frontier Communications, TAL Education Group, and Ekso Bionics — Fundamental Analysis, K
NEW YORK, Nov. 16, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dow Chemical Company (NYSE:DWDP), Bank Of...
Nov 08, 2017 04:05 pm ET
Ekso Bionics Reports Third Quarter 2017 Financial Results
- Company to Host Conference Call and Webcast Today at 4:30 p.m. ET / 1:30 p.m. PT -...
Nov 08, 2017 04:05 pm ET
Ekso Bionics Reports Third Quarter 2017 Financial Results
- Company to Host Conference Call and Webcast Today at 4:30 p.m. ET / 1:30 p.m. PT -
Nov 01, 2017 08:00 am ET
Ekso Bionics® to Report Third Quarter 2017 Financial Results on November 8, 2017
RICHMOND, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter...
Oct 10, 2017 08:00 am ET
Ekso Bionics® to Showcase the Latest Features of the EksoGT™ Wearable Exoskeleton at 2017 AAPM&R Annual Assembly
RICHMOND, Calif., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that the company will showcase the latest features of the EksoGT™ wearable exoskeleton at the 2017 American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly taking place October 12-15, 2017, in Denver, CO. For the first time at AAPM&R, attendees can learn how SmartAssist™ and EksoPulse™ technology can help them provide advanced personalized patient care....
Aug 14, 2017 08:46 am ET
Ekso Bionics® Announces Commencement of $34 Million Rights Offering
RICHMOND, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) (“Ekso” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced the commencement of its previously announced rights offering of common shares....
Aug 07, 2017 04:07 pm ET
Ekso Bionics Reports Second Quarter 2017 Financial Results
RICHMOND, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30, 2017. ...
Jun 26, 2017 08:00 am ET
Ekso Bionics® Added to Russell Microcap® Index
RICHMOND, Calif., June 26, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that the company has been selected to join the Russell Microcap®  Index as part of the annual Russell Equity Index Reconstitution, effective as of June 26....
May 23, 2017 08:00 am ET
Ekso Bionics Announces Cost Reductions to Lower Operating Expenses     
RICHMOND, Calif., May 23, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced plans to streamline its operations and reduce its workforce by approximately 25% to lower operating expenses and reduce cash burn.  The program intensifies Ekso’s focus on driving commercialization of its proprietary Ekso GT for rehabilitation and its exoskeleton offerings for industrial applications....
May 18, 2017 08:30 am ET
Ekso Bionics® to Present and Exhibit at the 6th International Conference of Rehabilitation Medicine and Engineering in Shanghai
RICHMOND, Calif., May 18, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that the company will be presenting and exhibiting at the 6th International Conference of Rehabilitation Medicine and Engineering (CRME 2017), being held in Shanghai, China, on May 20 – 21, 2017....
May 09, 2017 04:05 pm ET
Ekso Bionics Reports First Quarter 2017 Results
RICHMOND, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today reported financial results for the three months ended March 31, 2017. ...
Apr 25, 2017 04:05 pm ET
Ekso Bionics to Report First Quarter 2017 Financial Results on May 9, 2017
RICHMOND, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the first quarter 2017 after the close of trading on Tuesday, May 9, 2017.  The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments....
Mar 27, 2017 08:00 am ET
Ekso Bionics to Present at the Groundbreak 2017 Construction Conference
RICHMOND, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that Russ Angold, the company’s co-founder and chief technology officer, will be a presenter at the ProCore Groundbreak 2017 construction technology conference being held in Austin, Texas on March 29-31, 2017....
Mar 07, 2017 04:03 pm ET
Ekso Bionics Reports Fourth Quarter and Year End 2016 Results
RICHMOND, Calif., March 07, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today reported financial results for the three and twelve months ended December 31, 2016. ...
Feb 28, 2017 04:05 pm ET
Ekso Bionics to Present at the 29th Annual Roth Conference
RICHMOND, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced the company plans to participate in the 29th Annual Roth Conference in Orange County, CA....
Feb 28, 2017 08:00 am ET
Ekso Bionics® EksoZeroG Technology Named to Industry Hot List
RICHMOND, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, announced that its EksoZeroG industrial solution has been named to the industry recognized Hot List 2017. EksoZeroG was selected by Rental Management magazine from a record number of submissions as one of nearly 200 new products or services to be featured at The Rental Show® this year....
Feb 21, 2017 04:05 pm ET
Ekso Bionics to Report Fourth Quarter and Full Year 2016 Financial Results on March 7, 2017
RICHMOND, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the fourth quarter and full year 2016 after the close of trading on Tuesday, March 7, 2017.  The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments....
Jan 24, 2017 08:00 am ET
National Institute for Health and Care Excellence Releases Medtech Innovation Briefing on the Ekso GT Robotic Exoskeleton
RICHMOND, Calif., Jan. 24, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, announced today the release by the National Institute for Health and Care Excellence (NICE) of a Medtech Innovation Briefing (MIB) on the Ekso GT robotic exoskeleton.  The MIB highlights the innovative aspect of Ekso Bionics’ proprietary SmartAssist software, which differentiates the Ekso GT from other available wearable exoskeletons.   The MIB notes that SmartAssist technology allows physiotherapists to strategically target aspects of a patient's gait by providing ...
Jan 11, 2017 05:17 pm ET
Ekso Bionics® to Showcase New Industrial Construction Solution for Heavy Tool Handling at World of Concrete
RICHMOND, Calif., Jan. 11, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced it will showcase its innovative EksoZeroG technology at the World of Concrete (WOC 2017) event January 17-20, 2017, in Las Vegas. The EksoZeroG, a lightweight assistive device for industrial workers, provides an exciting new solution to enhance productivity and workmanship as well as to reduce work-related injuries on construction sites.  ...
Nov 30, 2016 04:05 pm ET
Ekso Bionics to Webcast Investor Day on December 6, 2016
RICHMOND, Calif., Nov. 30, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced it will host an Investor Day on December 6, 2016, in New York, NY. The presentation will begin at 8:00 a.m. (Eastern Time) followed by a question and answer session, and is expected to end at approximately 10:30 a.m., with product demonstrations also included in the morning session.  The presentation will be webcast live and may be accessed via the Ekso Bionics website at http://eksobionics.com under the Investor section. Materials accompanying the p...
Nov 09, 2016 04:05 pm ET
Ekso Bionics® Reports Third Quarter 2016 Results
RICHMOND, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today reported financial results for the three months ended September 30, 2016. ...
Oct 26, 2016 04:04 pm ET
Ekso Bionics to Report Third Quarter 2016 Financial Results on November 9, 2016
RICHMOND, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the third quarter 2016 after the close of trading on Wednesday, November 9, 2016. The Company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments....
Oct 26, 2016 06:30 am ET
Researchers to Present Latest Clinical Evidence for Ekso GT Robotic Exoskeleton at ACRM 93rd Annual Conference
RICHMOND, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that the company and its collaborators will exhibit the Ekso GT robotic exoskeleton at the American Congress of Rehabilitation in Medicine (ACRM) 93rd Annual Conference in Chicago, Illinois, taking place from October 30 to November 4, 2016.  The conference, which is the world’s largest interdisciplinary rehabilitation research conference, has a theme this year of “Improving lives through interdisciplinary rehabilitation research.”...
Oct 18, 2016 04:03 pm ET
Ekso Bionics to Exhibit Ekso GT Robotic Exoskeleton at AAPM&R and AMRPA Annual Meetings
RICHMOND, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that the company and its collaborators will exhibit their Ekso GT robotic exoskeleton in New Orleans at both the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly taking place October 20-23, 2016 and the American Medical Rehabilitation Providers Association (AMRPA) Annual Educational Conference taking place October 24-26, 2016.  ...
Oct 04, 2016 07:01 am ET
Ekso Bionics® Launches Ekso GT with Smart Assist
RICHMOND, Calif., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced it recently has shipped the first device incorporating SmartAssist, its next generation gait therapy software, allowing the company to expand the range of patients who can participate in robotic therapy....
Sep 19, 2016 07:00 am ET
AxoGen, Inc. Appoints Amy Wendell to Board of Directors  
ALACHUA, Fla., Sept. 19, 2016 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced the election of Amy Wendell to its Board of Directors effective September 16, 2016.  Ms. Wendell was also appointed to the Company’s Compensation and Governance Committees....
Sep 12, 2016 04:03 pm ET
Ekso Bionics Announces New Data to be Presented at 55th ISCoS Annual Scientific Meeting
RICHMOND, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that the company and its collaborators will have ten abstracts (one topical paper and nine posters) with data from 116 patients presented at the International Spinal Cord Society (ISCoS) Annual Scientific Meeting taking place September 14-16, 2016 in Vienna, Austria.  Of the 116 patients covered by these presentations, data from 54 patients are from the Ekso Bionics-sponsored Pan-Euro Study....
Sep 08, 2016 04:03 pm ET
Ekso Bionics Announces Appointment of Matthias Stief as Managing Director of Ekso Bionics Europe GmbH
RICHMOND, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced the appointment of Matthias Stief as Managing Director of Ekso Bionics Europe GmbH effective immediately.  In this position, Matthias will lead and manage all sales and marketing activities in the Europe, Middle East and Africa (EMEA) region....
Aug 30, 2016 09:40 am ET
Aug 29, 2016 10:00 am ET
Aug 29, 2016 07:00 am ET
Ekso Bionics to Present at the 2016 Gateway Conference
RICHMOND, Calif., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced the company plans to participate in the 5th Annual Gateway Conference hosted by the Liolios Group in San Francisco, CA....
Aug 22, 2016 08:30 am ET
Ekso Bionics Announces First Patient Enrolled in Important Multi-Center WISE Trial
RICHMOND, Calif., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced enrollment of the first patient in its first company-sponsored clinical trial, which will be led by Dr. Dylan Edwards, Ph.D., P.T., of The Burke Medical Research Institute,  a leading institution for neuro-rehabilitation. The randomized, controlled study, entitled WISE (Walking Improvement for SCI with Exoskeletons), will evaluate improvement in independent gait speeds of spinal cord injury (SCI) patients undergoing rehabilitation with the Ekso GT™, ...
Aug 12, 2016 11:00 am ET
Ekso Bionics Holdings Announces Closing of Public Offering of Common Stock
RICHMOND, Calif., Aug. 12, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced the closing of its previously announced public offering of 3,750,000 shares of common stock, at a price to the public of $4.00 per share. The net proceeds to the Company are expected to be $13.7 million, after deducting underwriting discounts and offering expenses payable by the Company.  The underwriters have been granted a 30-day option to purchase an additional 562,500 shares at the public offering price to cover over-allotments....
Aug 09, 2016 09:00 am ET
Ekso Bionics Holdings Announces Uplisting to Nasdaq Capital Market and Pricing of $15 Million Offering of Common Stock
RICHMOND, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (EKSO), a robotic exoskeleton company, today announced approval to list its common stock on the Nasdaq Capital Market. The Company’s common stock will begin trading under the symbol “EKSO” at the opening of trading on August 9, 2016....
Aug 08, 2016 04:05 pm ET
Ekso Bionics Holdings Announces Proposed Public Offering of Common Stock
RICHMOND, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. As part of the offering, the Company also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock to cover over-allotments, if any. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or term of the offering....
Jul 28, 2016 04:03 pm ET
Ekso Bionics® Reports Second Quarter 2016 Results
RICHMOND, Calif., July 28, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the three months ended June 30, 2016. ...
Jul 26, 2016 05:38 pm ET
Ekso Bionics to Report Second Quarter 2016 Financial Results on July 28, 2016
RICHMOND, Calif., July 26, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the second quarter 2016 after the close of trading on Thursday, July 28, 2016.  The Company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments....
Jul 07, 2016 04:03 pm ET
Ekso Bionics™ to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
RICHMOND, Calif., July 07, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that the company plans to participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference in New York City....
Jun 07, 2016 06:00 am ET
EKSO Bionics Robotic Exoskeletons Gain Global Connectivity With Vodafone IoT Technology
Vodafone will be connecting the world's first and only exoskeleton that is FDA cleared for use with both stroke patients and spinal cord injuries -- the Ekso GT™ (OTCQB: EKSO) from Ekso Bionics®. Vodafone's network and global Internet of Things (IoT) SIM will ensure reliable communications for diagnostics and improved access to patient data, helping to improve the user experience with the suit.
Jun 02, 2016 06:27 pm ET
Ekso Bionics Announces Inaugural Open House Event
RICHMOND, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that they will open their doors to the general public on the afternoon of Friday, June 10th, 2016. The open house will commence with a morning research preview for healthcare professionals, presented by thought leader Dr. Dylan Edwards.  Dr. Edwards will share his preliminary findings on how using Ekso GT, the only exoskeleton cleared for stroke, is helping his patients relearn to walk. Afternoon activities include a unique opportunity to experience a...
May 10, 2016 04:05 pm ET
Ekso Bionics® Reports First Quarter 2016 Results
RICHMOND, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO) (currently listed as OTCQB:EKSOD), a robotic exoskeleton company, today reported financial results for the three months ended March 31, 2016. ...
May 10, 2016 07:00 am ET
Ekso Bionics® To Showcase First FDA Cleared Exoskeleton Approved for Use with Stroke Patients at 9th World Congress for NeuroRehabilitation (WCNR)
RICHMOND, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSOD), a robotic exoskeleton company, today announced that it will be attending the 9th World Congress for NeuroRehabilitation (WCNR), taking place May 10-13, 2016 in Philadelphia, PA....
May 04, 2016 04:31 pm ET
Ekso Bionics announces 1-for-7 Reverse Stock Split in preparation for Proposed Uplisting to NASDAQ
RICHMOND, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it has effected a 1-for-7 reverse split of its common stock in preparation for its planned application for listing of its common stock on the NASDAQ Capital Market. The reverse stock split was approved by the company’s board of directors and is intended to allow the company to meet the minimum share price requirement for listing on the NASDAQ Capital Market. The company believes that it currently meets all of the listing requirements for listing t...
Apr 27, 2016 04:03 pm ET
Ekso Bionics to Report First Quarter 2016 Financial Results on May 10, 2016
RICHMOND, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the first quarter 2016 after the close of trading on Tuesday, May 10, 2016. The Company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments....